Form 8-K - Current report:
SEC Accession No. 0001193125-25-119861
Filing Date
2025-05-14
Accepted
2025-05-14 16:15:31
Documents
13
Period of Report
2025-05-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d919947d8k.htm   iXBRL 8-K 28079
  Complete submission text file 0001193125-25-119861.txt   150059

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA btmd-20250513.xsd EX-101.SCH 2833
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20250513_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20250513_pre.xml EX-101.PRE 11247
15 EXTRACTED XBRL INSTANCE DOCUMENT d919947d8k_htm.xml XML 3634
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 25945728
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)